Using IL‐2R/lymphocytes for predicting the clinical progression of patients with COVID‐19

Effective laboratory markers for the estimation of disease severity and predicting the clinical progression of coronavirus disease‐2019 (COVID‐19) is urgently needed. Laboratory tests, including blood routine, cytokine profiles and infection markers, were collected from 389 confirmed COVID‐19 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, H., Zhang, B., Huang, H., Luo, Y., Wu, S., Tang, G., Liu, W., Mao, L., Wang, F., Sun, Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267633/
https://www.ncbi.nlm.nih.gov/pubmed/32365221
http://dx.doi.org/10.1111/cei.13450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267633/
https://www.ncbi.nlm.nih.gov/pubmed/32365221
http://dx.doi.org/10.1111/cei.13450

Ejemplares similares